DEPARTMENT OF HEALTH
Clinical Trials
287
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (261 trials with phase data)• Click on a phase to view related trials
Textbook Outcomes After Oesophagectomy in Regional Australia
- Conditions
- Oesophageal Cancer Nos
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Launceston General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06721715
- Locations
- 🇦🇺
Launceston General Hospital, Launceston, Tasmania, Australia
Post Oesophagectomy Outcomes in a Single Regional Centre in Australia
- Conditions
- Oesophageal Cancer
- First Posted Date
- 2024-10-29
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Launceston General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06662513
- Locations
- 🇦🇺
Launceston General Hospital, Launceston, Tasmania, Australia
A Randomised, Blinded Study on Laparoscopic Mesh Reinforcement for Chronic Groin Pain
- Conditions
- Chronic Groin Pain
- First Posted Date
- 2009-07-08
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- Royal Hobart Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT00934388
- Locations
- 🇦🇺
Royal Hobart Hospital, Hobart, Tasmania, Australia
U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis
- Conditions
- Haemodialysis
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- Royal Hobart Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT00829153
- Locations
- 🇦🇺
Launceston general Hospital, Launceston, Australia
A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery
- First Posted Date
- 2007-07-13
- Last Posted Date
- 2017-04-12
- Lead Sponsor
- Royal Hobart Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT00500669
- Locations
- 🇦🇺
Royal Hobart Hospital, Hobart, Tasmania, Australia
- Prev
- 1
- 2
- Next
News
Hong Kong Establishes Independent Drug Regulatory Authority by End 2026, Ending Reliance on Foreign Approvals
Hong Kong will launch its own drug and medical device regulator by late 2026, marking a significant shift from the current secondary evaluation system that requires approval from at least two overseas regulators.
Hong Kong Streamlines Drug Registration Process with New Consultation Services
Hong Kong's Department of Health is launching consultation services to help pharmaceutical companies navigate the "1+" drug registration mechanism, starting with an online seminar on March 31, 2025.
Philippine Senator Urges Fast-Track Approval of Takeda's TAK-003 Dengue Vaccine Amid 56% Case Surge
Philippines reports a dramatic 56% increase in dengue cases during the first six weeks of 2025, with over 43,000 cases recorded across key regions including Calabarzon, Metro Manila, and Central Luzon.
Philippine Clinical Trial for Virgin Coconut Oil as COVID-19 Treatment Expected to Conclude by December
A clinical trial in the Philippines is evaluating virgin coconut oil (VCO) as a potential treatment for COVID-19, with results anticipated by December.